Search for: "Abbott Diabetes Care Inc."
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
24 Jan 2024, 4:29 am
Jane Lambert Patents Court (Mr Justice Richards) Abbott Diabetes Care Inc and others v Dexcom Inc and others [2023] EWHC 2591 (Ch) (18 Oct 2023)This was a claim by Abbot Daiabetes Care Inc and others ("Abbott") for infringement of European patent (UK) 2549918B1 for Medical device inserters and processes of inserting and using medical devices and a counterclaim by Dexcom Inc [read post]
13 May 2010, 9:34 pm
• Brief of Plaintiff-Appellants Abbott Laboratories and Abbott Diabetes Care, Inc. [read post]
16 May 2010, 9:47 pm
The Court originally gave Plaintiffs-Appellants Abbott Diabetes Care, Inc. [read post]
3 Jan 2024, 1:15 pm
DexCom and Abbott Diabetes Care, Inc. entered into a settlement and license agreement in 2014, following years of patent litigation over their competing glucose monitoring system patents. [read post]
3 Jan 2024, 1:15 pm
DexCom and Abbott Diabetes Care, Inc. entered into a settlement and license agreement in 2014, following years of patent litigation over their competing glucose monitoring system patents. [read post]
29 Sep 2012, 2:16 pm
California - The Federal Circuit on Friday resurrected two Abbott Diabetes Care Inc. patents for a diabetes-related glucose monitoring system, ruling that the U.S. [read post]
28 Apr 2010, 9:59 pm
In the Court's per curiam order, it noted that the panel that heard the appeal considered the petition for rehearing submitted by Plaintiffs-Appellants Abbott Diabetes Care, Inc. [read post]
3 Jan 2024, 9:27 am
Abbott Diabetes Care, Inc., 2023-1795 (Fed. [read post]
9 Jun 2010, 9:59 pm
In April, the Federal Circuit granted a petition for rehearing en banc submitted by Plaintiffs-Appellants Abbott Diabetes Care, Inc. [read post]
7 Mar 2011, 1:35 pm
Abbott Diabetes Care, et al., C.A. [read post]
6 Dec 2014, 4:46 am
Abbott Diabetes Care, Inc., et al., Civil Action No. 07-753-RGA (D.Del., December 5, 2014), the Court, on remand from the United States Court of Appeals for the Federal Circuit, construed the term “electrode” consistent with the Court’s original construction of that term before plaintiff’s appeal to the Federal Circuit of the denial of plaintiff’s motion for reconsideration and the entry of summary judgment of non-infringement based… [read post]
19 Feb 2019, 12:25 pm
On February 19, the Department of Justice announced that it was intervening in a whistleblower’s qui tam lawsuit against two companies involved in health care for people suffering from diabetes – Arriva Medical, LLC and Alere, Inc. [read post]
6 Oct 2020, 7:17 am
Plaintiffs Abbott Laboratories, Abbott Diabetes Care Inc., and Abbott Diabetes Care Sales Corp. [read post]
6 Oct 2020, 7:17 am
Plaintiffs Abbott Laboratories, Abbott Diabetes Care Inc., and Abbott Diabetes Care Sales Corp. [read post]
6 Oct 2020, 7:17 am
Plaintiffs Abbott Laboratories, Abbott Diabetes Care Inc., and Abbott Diabetes Care Sales Corp. [read post]
18 Sep 2009, 3:17 pm
Abbott Diabetes Care Incorporated, C.A. 07-753-JJF (D. [read post]
17 Mar 2014, 7:20 pm
(now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories (collectively, Abbott).Therasense at *2. [read post]
15 Sep 2018, 2:00 pm
BD Completes Bard Acquisition, Creating New Global Health Care Leader. [read post]
4 Oct 2012, 3:55 am
Earlier this week, the agency was reversed again, due to the guidance of the patent specification in In re Abbott Diabetes Care Inc. [read post]
En Banc Federal Circuit Appeals Court Tightens Materiality and Intent Prongs for Inequitable Conduct
2 Jun 2011, 8:19 am
In the instant case, the lower court had found inequitable conduct by Abbott Diabetes Care Inc., the successor to Therasense Inc. and a subsidiary of Abbott Laboratories as to patents (5,628,890; 5,820,551; 6,143,164; and 6,592,745) directed to a glucose home testing kit for diabetics, including disposable blood glucose test strips. [read post]
